Manipulating Milestones In Pandemic Times With AGTC's Sue Washer (Bioprocess Online)

Manipulating Milestones in Pandemic Times with AGTC’s Sue Washer

The COVID-19 pandemic continues to disrupt biopharma clinical trials, especially those conducted with at-risk patient populations. From patient recruitment to data collection, clinical trials execution became considerably more challenging in 2020. On this episode of The Business Of Biotech, UF startup and UF Innovate | Sid Martin Biotech graduate AGTC CEO Sue Washer gives us a behind-the-scenes look at the creative measures her company took to serve a geographically dispersed clinical patient population and ensure her company met clinical milestones.

Listen to AGTC CEO Sue Washer in the podcast about Manipulating Milestones in Pandemic Times with AGTC’s Sue Washer.
X